Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q1 2024 · 10-Q
Revenue$9.12M$9.12M−64.7% vs Q1 2023 Net Income-$2.91M-$2.91MN/M vs Q1 2023 EPS Diluted-$0.65-$0.65N/M vs Q1 2023 Gross Profit$2,902,000−30.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flow-$168,000N/M Free Cash Flowderived-$198,000— Margins · derivedGross margin31.8%+15.6 pt vs Q1 2023
Operating margin-29.5%−30.8 pt vs Q1 2023
Net margin-31.9%−32.8 pt vs Q1 2023
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end